Evaluating the baseline hemoglobin, albumin, lymphocyte, and platelet (HALP) score in the United States adult population and comorbidities: an analysis of the NHANES R Antar, C Farag, V Xu, A Drouaud, O Gordon, MJ Whalen Frontiers in Nutrition 10, 1206958, 2023 | 9 | 2023 |
Rare adrenal cavernous hemangioma: a case report highlighting diagnostic challenges RM Antar, CM Farag, K Youssef, V Xu, A Drouaud, N Panitch, Z Tariq, ... Frontiers in Surgery 10, 1293925, 2023 | 1 | 2023 |
Gender disparities in metastatic RCC therapies and outcomes. OF Gordon, R Nadjafi, V Xu, A Drouaud, MJ Whalen, Y Wang Journal of Clinical Oncology 41 (16_suppl), 4565-4565, 2023 | 1 | 2023 |
Novel immunotherapies and targeted molecular therapies for non-muscle invasive bladder cancer: a literature review AP Drouaud, B Boyarsky, Y Wang, R Antar, N Sivanesan, VE Xu, ... AME Medical Journal 10, 2025 | | 2025 |
Analysis of neoadjuvant chemotherapy utilization, pathologic response, and overall survival in upper tract urothelial carcinoma VE Xu, O Adesanya, S Azari, S Islam, M Klein, A Drouaud, RM Antar, ... Clinical Genitourinary Cancer, 102224, 2024 | | 2024 |
Oncologic outcomes of neoadjuvant chemotherapy and lymph node dissection with partial cystectomy for muscle-invasive bladder cancer RM Antar, VE Xu, CM Farag, J Lucero, A Drouaud, V Sundaresan, ... Translational Andrology and Urology 13 (8), 1349363-1341363, 2024 | | 2024 |
Definitive Local Treatment for Metastatic Prostate Cancer: A National Cancer Database Analysis M Whalen, P Nagao, J Luu, R Antarmw, A Drouaud, V Xu, B Boyarsky, ... Medical Research Archives 12 (8), 2024 | | 2024 |
Metastatic Tropism in Urothelial Carcinoma with Variant Histology: A Comprehensive NCDB Analysis A Drouaud, V Xu, A Velasquez, R Antar, B Boyarsky, J Weiss, D Gonzalez, ... Clinical Genitourinary Cancer, 102179, 2024 | | 2024 |
Performance characteristics of ExoDx urinary biomarker: A single-institution analysis. A Murdock, VE Xu, RM Antar, F Pio, N Bowler, MJ Whalen Journal of Clinical Oncology 42 (16_suppl), e17090-e17090, 2024 | | 2024 |
Utilization of neoadjuvant chemotherapy (NAC) and pathologic outcomes in upper tract urothelial carcinoma (UTUC). VE Xu, S Azari, MN Klein, A Drouaud, P Chang, RM Antar, OF Gordon, ... Journal of Clinical Oncology 42 (16_suppl), e16620-e16620, 2024 | | 2024 |
Online Interest in Urology Residency: A Comprehensive Analysis of Current Internet Temporal and Geographic Patterns A Drouaud, R Antar, V Xu, P Nagao, S Tafuri, M Whalen International Medical Education 3 (2), 160-170, 2024 | | 2024 |
Income Disparities in Survival and Receipt of Neoadjuvant Chemotherapy and Pelvic Lymph Node Dissection for Muscle-Invasive Bladder Cancer RM Antar, VE Xu, O Adesanya, A Drouaud, N Longton, O Gordon, ... Current Oncology 31 (5), 2566-2581, 2024 | | 2024 |
MP08-18 METASTATIC BEHAVIOR OF UROTHELIAL CARCINOMA VARIANT HISTOLOGY: A COMPREHENSIVE NCDB ANALYSIS AP Drouaud, VE Xu, RM Antar, A Velasquez, MJ Whalen Journal of Urology 211 (5S), e123, 2024 | | 2024 |
MP77-17 PERIOPERATIVE OUTCOMES OF RADICAL CYSTECTOMY WITH HISTORY OF PRIOR PELVIC RADIATION RE Fuller, R Simhal, RM Antar, VE Xu, N Bowler, MJ Whalen Journal of Urology 211 (5S), e1259, 2024 | | 2024 |
MP22-06 INCOME DISPARITIES IN SURVIVAL AND RECEIPT OF NEOADJUVANT CHEMOTHERAPY AND LYMPH NODE DISSECTION FOR MUSCLE-INVASIVE BLADDER CANCER RM Antar, VE Xu, A Drouaud, OF Gordon, S Azari, B Goddard, S Tafuri, ... The Journal of Urology 211 (5S), e343, 2024 | | 2024 |
Efficacy of cytoreductive radical cystectomy in metastatic urothelial bladder cancer based on site and number of metastases VE Xu, RM Antar, L Bertozzi, A Drouaud, S Azari, SM Lee, MJ Whalen Urologic Oncology: Seminars and Original Investigations 42 (5), 162. e11-162 …, 2024 | | 2024 |
EFFICACY OF CYTOREDUCTIVE CYSTECTOMY IN METASTATIC UROTHELIAL BLADDER CANCER BASED ON SITE OF METASTASIS VE Xu, RM Antar, S Azari, OF Gordon, MJ Whalen Urologic Oncology: Seminars and Original Investigations 42, S32, 2024 | | 2024 |
Analysis of neoadjuvant immunotherapy and chemotherapy for muscle-invasive bladder cancer in a national registry. MN Klein, VE Xu, OF Gordon, RM Antar, MJ Whalen Journal of Clinical Oncology 42 (4_suppl), 611-611, 2024 | | 2024 |